1. Introduction
This decision addresses the relationship between an established workers’ compensation claim for COVID-19 and a subsequent request to recognize Long COVID. Its central distinction is between the procedural labeling of a condition and medical proof connecting continuing symptoms to the compensable infection.
Susan Hahnenfeld, a registered nurse, had already established that her April 2020 COVID-19 infection was work-related. She later sought to amend her claim to include Long COVID. Although a Workers’ Compensation Law Judge granted that amendment, the Workers’ Compensation Board ultimately found insufficient medical evidence connecting her later symptoms and disability to the April 2020 infection. The Appellate Division affirmed.
The opinion explains, through the Board authorities it invokes, that ongoing symptoms attributable to an established COVID-19 infection do not require a separate Long COVID amendment. Nevertheless, the claimant must establish the necessary causal relationship. An accepted initial infection does not automatically establish that every later symptom or period of disability arose from that infection.
4. Analysis
A. The Medical Evidence and Its Limitations
| Physician |
Evidence |
Significance to Causation |
| Mill Etienne, treating neurologist |
First examined Hahnenfeld in January 2022 and diagnosed Long COVID, maintaining that diagnosis in March 2022. He attributed her symptoms to the prior infection because they began after April 2020. |
He did not know when her second COVID-19 infection occurred. Diagnostic studies did not fully explain her symptoms. These limitations affected the Board’s assessment of the opinion’s causal foundation. |
| Billy Ford, physician and Board-certified anesthesiologist |
First treated Hahnenfeld in August 2021. He did not diagnose Long COVID and described an ongoing inflammatory process as the source of many symptoms. |
His testimony did not supply a clear Long COVID diagnosis linking the claimed condition to the April 2020 infection. |
| Carl Friedman, pulmonary and internal medicine specialist |
Examined Hahnenfeld in September 2022 and testified that COVID-19 exacerbated significant preexisting musculoskeletal problems. |
The record did not reflect that he knew about her second COVID-19 infection, limiting the testimony’s value in identifying the relevant infection. |
Hahnenfeld reported thigh and knee pain, hand tremors, walking and standing difficulties, reduced exercise tolerance, leg tingling, anxiety, and urinary incontinence. She also disclosed an autoimmune disorder, hypertension, and cancer. According to her history, symptoms began after April 2020 and worsened around July 2021. She contracted COVID-19 again around December 2021.
The second infection mattered because the claim rested on the established April 2020 workplace infection. A general attribution of symptoms to “COVID-19” did not necessarily resolve which infection caused the claimed condition. The Board could also consider whether the medical opinions adequately addressed her other conditions.
Importantly, the court did not find that the second infection actually caused the disability. Nor could that later infection explain, by chronology alone, symptoms reportedly worsening months earlier. The narrower conclusion was that incomplete medical histories and insufficiently developed causal explanations supported the Board’s finding that Hahnenfeld had not carried her burden.
B. Precedents Cited and Their Influence
Workplace COVID-19 as a Compensable Hazard
Matter of Hogan v ABF Frgt. Sys., Inc., 246 AD3d 1201, 1202 (3d Dept 2026), supplies the opening proposition that workplace COVID-19 reasonably qualifies as an unusual hazard rather than the natural and unavoidable result of employment. This establishes the legal foundation for compensation while separating the accepted initial infection from the disputed later consequences.
The Board’s Fact-Finding Role and Appellate Review
Matter of Brennan v Village of Johnson City, 213 AD3d 1058, 1059-1060 (3d Dept 2023), performs two functions. First, it identifies causation as a factual issue entrusted to the Board, whose determination must stand when supported by substantial evidence. Second, it confirms the Board’s authority to resolve conflicting medical opinions. These principles explain why the appellate court did not independently choose the medical interpretation it considered most persuasive.
Matter of Blanch v Delta Air Lines, 204 AD3d 1203, 1205 (3d Dept 2022), reinforces that the Board may resolve medical conflicts and draw reasonable inferences from the record. Its importance extends beyond direct disagreements between doctors: the Board may assess gaps in their knowledge and the adequacy of their causal explanations.
The Claimant’s Medical-Proof Burden
Matter of Christensen-Mavrigiannakis v Nomura Sec. Intl., Inc., 175 AD3d 1748, 1752 (3d Dept 2019), establishes the claimant’s obligation to demonstrate, through competent medical evidence, a causal connection between employment and the claimed disability. Here, the accepted workplace infection did not remove the need to connect the later disability to that infection.
Matter of Martinez v Domino Foods, Inc., 234 AD3d 1069, 1070-1071 (3d Dept 2025), is cited in further support of that burden. The opinion does not describe its underlying facts; its stated relevance is the continuing requirement of competent medical causation evidence.
Long COVID Within an Existing Claim
Employer: Wal-Mart Assoc. Inc., 2025 WL 1147034, *3-4, 2025 NY Wrk Comp LEXIS 1851, *8-10 (WCB No. G341 3702, Apr. 14, 2025), is the principal administrative authority explaining how Long COVID fits within an established claim. It distinguishes:
- Ongoing symptoms: Long-term manifestations of the established infection may support compensation for treatment and lost time without amending the claim to add “Long COVID.”
- Discrete consequential injuries: Additional, distinct conditions attributed to COVID-19 must be established through sufficient medical evidence connecting them to the compensable infection.
The court also cites this decision by comparison when affirming the result. The supplied opinion does not recount its underlying medical record, so the comparison should not be expanded into an unsupported factual analogy.
Employer: NYC Transit Auth., 2026 WL 1051419, *6, 2026 NY Wrk Comp LEXIS 2842, *16 (WCB No. G315 1913, Apr. 10, 2026), accords with the proposition that Long COVID manifestations are treated as ongoing symptoms rather than a separate or consequential claim merely because they carry that diagnostic label.
These are Board decisions, not appellate judgments. Their significance here is that the Appellate Division expressly invokes their framework in explaining the treatment of Long COVID claims.
Authorities Supporting Affirmance on This Record
Matter of Becker v United Cerebral Palsy Assoc., 231 AD3d 1255, 1257 (3d Dept 2024), appeal dismissed 44 NY3d 1029 (2025), and Matter of Kot v Beth Ameth Home Attendant Serv., 70 AD3d 1114, 1115 (3d Dept 2010), support leaving the Board’s adverse causation determination undisturbed. The opinion does not reproduce their facts or characterize them as Long COVID cases. Their role is to reinforce the application of established evidentiary and review principles. The dismissal of the appeal in Matter of Becker v United Cerebral Palsy Assoc. should not be confused with an affirmance on the merits.
C. Legal Reasoning
1. Diagnosis and Work-Related Causation Are Different Questions
A physician’s Long COVID diagnosis does not necessarily establish that a particular compensable infection caused the claimant’s disability. Etienne’s testimony supported a relationship between symptoms and an earlier infection, but the Board could evaluate whether that explanation adequately addressed reinfection, other illnesses, and the clinical record.
The court did not hold that a physician’s use of the word “probably” automatically defeats causation. It assessed the testimony in context. Likewise, the absence of diagnostic findings fully explaining the symptoms was part of the evidentiary picture—not the announcement of a universal requirement for an objective Long COVID test.
2. No Separate Amendment Does Not Mean No Proof
The apparent tension in the decision is that the court explains why a Long COVID amendment is unnecessary, yet affirms denial of the requested amendment. The distinction is substantive: the Board did not merely reject a label; it found the necessary causal connection inadequately established.
Accordingly, dispensing with a separate amendment simplifies claim administration but does not create a presumption that later symptoms arise from the accepted infection. The claimant must still establish that the treatment or lost time for which compensation is sought relates to that infection.
3. Preliminary Evidence Is Not a Final Finding
The July 2022 finding of prima facie medical evidence did not settle ultimate causation. It recognized a sufficient preliminary medical basis to develop the issue. The Board remained entitled to assess the completed record, including deposition testimony revealing weaknesses not apparent from the initial reports.
4. Substantial Evidence Limits Appellate Reweighing
The appellate question was not whether evidence could support Hahnenfeld’s position, but whether substantial evidence supported the Board’s determination. The court concluded that it did. The treating neurologist’s favorable opinion therefore did not compel reversal, and the appellate court did not substitute its assessment for the Board’s permissible evaluation.
D. Impact and Limits
For claimants: The decision favors careful medical histories over reliance on a diagnostic label. Where there have been multiple infections, a persuasive opinion should address their timing, the development of symptoms, and why the claimed disability is attributable to the established workplace infection.
For employers and other responding parties: Relevant evidentiary questions include whether physicians knew about reinfections and other medical conditions, and whether they explained the connection to the compensable episode. The decision does not establish that merely identifying another possible cause automatically defeats a claim.
For claim administration: The opinion discourages unnecessary amendments solely to add the Long COVID label. At the same time, its distinction between ongoing symptoms and discrete consequential injuries preserves the need to establish genuinely additional conditions.
For future appeals: The substantial-evidence standard makes the quality and completeness of the record before the Board particularly important. A favorable medical opinion may not secure reversal if the Board reasonably identifies material weaknesses in its foundation.
The holding is limited. It neither declares Long COVID noncompensable nor revokes the established April 2020 claim. It creates no categorical bar for claimants with reinfections or preexisting illnesses and announces no exhaustive medical criteria for Long COVID.